Neurobiology of Disease, 0969-9961

Journal

More filtering options
  1. 1997
  2. Studies on neuroprotective and regenerative effects of GDNF in a partial lesion model of Parkinson's disease

    Anders Björklund, Rosenblad, C., Winkler, C. & Deniz Kirik, 1997, In : Neurobiology of Disease. 4, 3-4, p. 186-200

    Research output: Contribution to journalReview article

  3. 2001
  4. Alterations in cortical and basal ganglia levels of opioid receptor binding in a rat model of L-DOPA-induced dyskinesia

    Johansson, P. A., Andersson, M., Andersson, K. E. & M. A. Cenci, 2001, In : Neurobiology of Disease. 8, 2, p. 220-239 20 p.

    Research output: Contribution to journalArticle

  5. Alterations of Akt1 (PKBalpha) and p70(S6K) in transient focal ischemia

    S Janelidze, Hu, BI-R., P Siesjö & Siesjö, B. K., 2001 Feb, In : Neurobiology of Disease. 8, 1, p. 147-154

    Research output: Contribution to journalArticle

  6. 2002
  7. Evidence for Dysfunction of the Nigrostriatal Pathway in the R6/1 Line of Transgenic Huntington's Disease Mice.

    Åsa Petersén, Puschban, Z., Lotharius, J., NicNiocaill, B., Wiekop, P., O'Connor, W. T. & Brundin, P., 2002, In : Neurobiology of Disease. 11, 1, p. 134-146

    Research output: Contribution to journalArticle

  8. Interactions of A beta with endogenous anti-inflammatory agents: a basis for chronic neuroinflammation in Alzheimer's disease.

    Sabina Janciauskiene, Sun, Y. & Wright, H. T., 2002, In : Neurobiology of Disease. 10, 3, p. 187-200

    Research output: Contribution to journalReview article

  9. 2003
  10. Death mechanisms in status epilepticus-generated neurons and effects of additional seizures on their survival.

    Christine Ekdahl Clementson, Zhu, C., Bonde, S., Bahr, B. A., Blomgren, K. & Olle Lindvall, 2003, In : Neurobiology of Disease. 14, 3, p. 513-523

    Research output: Contribution to journalArticle

  11. Kindling alters entorhinal cortex-hippocampal interaction by increased efficacy of presynaptic GABA(B) autoreceptors in layer III of the entorhinal cortex

    Gloveli, T., Behr, J., Dugladze, T., Zaal Kokaia, Merab Kokaia & Heinemann, U., 2003, In : Neurobiology of Disease. 13, 3, p. 203-212

    Research output: Contribution to journalArticle

  12. Targeted expression of BCL-2 attenuates MPP+ but not 6-OHDA induced cell death in dopaminergic neurons

    O'Malley, KL., Liu, J., Lotharius, J. & Holtz, W., 2003, In : Neurobiology of Disease. 14, 1, p. 43-51

    Research output: Contribution to journalArticle

  13. 2004
  14. A model of L-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function.

    Lundblad, M., Picconi, B., Lindgren, H. & Angela Cenci Nilsson, 2004, In : Neurobiology of Disease. 16, 1, p. 110-123

    Research output: Contribution to journalArticle

  15. Effects of pulsatile L-DOPA treatment in the double lesion rat model of striatonigral degeneration (multiple system atrophy)

    Stefanova, N., Lundblad, M., Tison, F., Poewe, W., Angela Cenci Nilsson & Wenning, GK., 2004, In : Neurobiology of Disease. 15, 3, p. 630-639

    Research output: Contribution to journalArticle

  16. Transcriptome analysis in a rat model of L-DOPA-induced dyskinesia

    Konradi, C., Jenny Westin, Carta, M., Eaton, ME., Kuter, K., Dekundy, A., Lundblad, M. & Angela Cenci Nilsson, 2004, In : Neurobiology of Disease. 17, 2, p. 219-236

    Research output: Contribution to journalArticle

  17. 2005
  18. Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to beta-amyloid deposition in APP/PS1 double transgenic Alzheimer mice

    Malm, T. M., Koistinaho, M., Parepalo, M., Vatanen, T., Ooka, A., Stefan Karlsson & Koistinahoa, J., 2005, In : Neurobiology of Disease. 18, 1, p. 134-142

    Research output: Contribution to journalArticle

  19. Cystatin C modulates neurodegeneration and neurogenesis following status epilepticus in mouse

    Pirttila, T. J., Lukasiuk, K., Håkansson, K., Anders Grubb, Magnus Abrahamson & Pitkanen, A., 2005, In : Neurobiology of Disease. 20, 2, p. 241-253

    Research output: Contribution to journalArticle

  20. Differential suppression of seizures via Y2 and Y5 neuropeptide Y receptors.

    Woldbye, D. P. D., Nanobashvili, A., Toft Sörensen, A., Husum, H., Bolwig, T. G., Sørensen, G., Ernfors, P. & Merab Kokaia, 2005, In : Neurobiology of Disease. 20, 3, p. 760-772

    Research output: Contribution to journalArticle

  21. Reduced hippocampal neurogenesis in R6/2 transgenic Huntington's disease mice.

    Gil, J., Mohapel, P., Araujo, I., Popovic, N., Jia-Yi Li, Brundin, P. & Åsa Petersén, 2005, In : Neurobiology of Disease. 20, 3, p. 744-751

    Research output: Contribution to journalArticle

  22. 2006
  23. Genetically determined susceptibility to neurodegeneration is associated with expression of inflammatory genes

    Maria Swanberg, Duvefelt, K., Diez, M., Hillert, J., Olsson, T., Piehl, F. & Lidman, O., 2006, In : Neurobiology of Disease. 24, 1, p. 67-88 22 p.

    Research output: Contribution to journalArticle

  24. The impact of graft size on the development of dyskinesia following intrastriatal grafting of embryonic dopamine neurons in the rat.

    Lane, E., Winkler, C., Brundin, P. & Angela Cenci Nilsson, 2006, In : Neurobiology of Disease. 22, 2, p. 334-345

    Research output: Contribution to journalArticle

  25. Ventral tegmental area dopamine neurons are resistant to human mutant alpha-synuclein overexpression.

    Maingay, M., Romero-Ramos, M., Carta, M. & Deniz Kirik, 2006, In : Neurobiology of Disease. 23, 3, p. 522-532

    Research output: Contribution to journalArticle

  26. 2007
  27. Nerve growth factor promotes survival of new neurons in the adult hippocampus.

    Frielingsdorf, H., Simpson, D. R., Thal, L. J. & Pizzo, D. P., 2007, In : Neurobiology of Disease. 26, 1, p. 47-55

    Research output: Contribution to journalArticle

  28. Re-evaluation of mitochondrial permeability transition as a primary neuroprotective target of minocycline.

    Månsson, R., Magnus Hansson, Morota, S., Uchino, H., Christine Ekdahl Clementson & Eskil Elmer, 2007, In : Neurobiology of Disease. 25, p. 198-205

    Research output: Contribution to journalArticle

  29. Testicular degeneration in Huntington disease

    Van Raamsdonk, J. M., Murphy, Z., Selva, D. M., Hamidizadeh, R., Pearson, J., Åsa Petersén, Maria Björkqvist, Muir, C., Mackenzie, I. R., Hammond, G. L., Vogl, A. W., Hayden, M. R. & Leavitt, B. R., 2007, In : Neurobiology of Disease. 26, 3, p. 512-520

    Research output: Contribution to journalArticle

  30. 2008
  31. Increased metabolism in the R6/2 mouse model of Huntington's disease.

    van der Burg, J. M., Karl Bacos, Wood, N. I., Andreas Lindqvist, Nils Wierup, Woodman, B., Wamsteeker, J., Ruben Smith, Tomas Deierborg, Kuhar, M. J., Bates, G. P., Hindrik Mulder, Charlotte Erlanson-Albertsson, Morton, J., Brundin, P., Åsa Petersén & Maria Björkqvist, 2008, In : Neurobiology of Disease. 29, 1, p. 41-51

    Research output: Contribution to journalArticle

  32. l-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiation

    Picconi, B., Paille, V., Ghiglieri, V., Bagetta, V., Barone, I., Lindgren, H., Bernardi, G., Angela Cenci Nilsson & Calabresi, P., 2008, In : Neurobiology of Disease. 29, 2, p. 327-335

    Research output: Contribution to journalArticle

  33. Neuroinflammation in the generation of post-transplantation dyskinesia in Parkinson's disease.

    Lane, E., Soulet, D., Vercammen, L., Angela Cenci Nilsson & Brundin, P., 2008, In : Neurobiology of Disease. 32, p. 220-228

    Research output: Contribution to journalArticle

  34. 2009
  35. Increased levels of cocaine and amphetamine regulated transcript in two animal models of depression and anxiety.

    Wiehager, S., Beiderbeck, D. I., Gruber, S. H. M., El-Khoury, A., Wamsteeker, J., Neumann, I. D., Åsa Petersén & Mathé, A. A., 2009, In : Neurobiology of Disease. 34, p. 375-380

    Research output: Contribution to journalArticle

  36. 2010
  37. A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeys.

    Daniella Rylander, Iderberg, H., Li, Q., Dekundy, A., Zhang, J., Li, H., Baishen, R., Danysz, W., Bezard, E. & Angela Cenci Nilsson, 2010, In : Neurobiology of Disease. 39, p. 352-361

    Research output: Contribution to journalArticle

  38. Early changes in the hypothalamic region in prodromal Huntington disease revealed by MRI analysis.

    Soneson, C., Fontes, M., Zhou, Y., Vladimir Denisov, Paulsen, J. S., Deniz Kirik & Åsa Petersén, 2010, In : Neurobiology of Disease. 40, p. 531-543

    Research output: Contribution to journalArticle

  39. 2011
  40. Apoptosis-inducing factor mediates dopaminergic cell death in response to lps-induced inflammatory stimulus Evidence in Parkinson's disease patients.

    Burguillos Garcia, M., Hajji, N., Englund, E., Persson, A., Angela Cenci Nilsson, Machado, A., Cano, J., Joseph, B. & Venero, J. L., 2011, In : Neurobiology of Disease. 41, p. 177-188

    Research output: Contribution to journalArticle

  41. Cleavage of the vesicular glutamate transporters under excitotoxic conditions

    Lobo, A. C., Gomes, J. R., Catarino, T., Mele, M., Fernandez, P., Inacio, A., Bahr, B. A., Santos, A. E., Tadeusz Wieloch, Carvalho, A. L. & Duarte, C. B., 2011, In : Neurobiology of Disease. 44, 3, p. 292-303

    Research output: Contribution to journalArticle

  42. Gastrointestinal dysfunction contributes to weight loss in Huntington's disease mice.

    van der Burg, J. M., Winqvist, A., Aziz, N. A., Maat-Schieman, M. L. C., Roos, R. A. C., Bates, G. P., Brundin, P., Maria Björkqvist & Nils Wierup, 2011, In : Neurobiology of Disease. 44, p. 1-8

    Research output: Contribution to journalArticle

  43. 2012
  44. Combined gene overexpression of neuropeptide Y and its receptor Y5 in the hippocampus suppresses seizures

    Gotzsche, C. R., Nikitidou, L., Toft Sörensen, A., Olesen, M. V., Sorensen, G., Christiansen, S. H. O., Ängehagen, M., Woldbye, D. P. D. & Merab Kokaia, 2012, In : Neurobiology of Disease. 45, 1, p. 288-296

    Research output: Contribution to journalArticle

  45. Dysregulated dopamine storage increases the vulnerability to alpha-synuclein in nigral neurons

    Ulusoy, A., Tomas Björklund, Buck, K. & Deniz Kirik, 2012, In : Neurobiology of Disease. 47, 3, p. 367-377

    Research output: Contribution to journalArticle

  46. Key factors determining the efficacy of gene therapy for continuous DOPA delivery in the Parkinsonian brain

    Cederfjäll, E., Gurdal Sahin & Deniz Kirik, 2012, In : Neurobiology of Disease. 48, 2, p. 222-227

    Research output: Contribution to journalReview article

  47. Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of α-synuclein in midbrain dopamine neurons.

    Decressac, M., Mattsson, B., Lundblad, M., Weikop, P. & Anders Björklund, 2012, In : Neurobiology of Disease. 45, 3, p. 939-953

    Research output: Contribution to journalArticle

  48. Serotonergic and dopaminergic mechanisms in graft-induced dyskinesia in a rat model of Parkinson's disease.

    Shin, E., Garcia, J., Winkler, C., Anders Björklund & Carta, M., 2012, In : Neurobiology of Disease. 47, 3, p. 393-406

    Research output: Contribution to journalArticle

  49. Special Issue: Viral delivery of genes: new frontiers Introduction

    Kordower, J. H. & Deniz Kirik, 2012, In : Neurobiology of Disease. 48, 2, p. 151-152

    Research output: Contribution to journalDebate/Note/Editorial

  50. 2013
  51. A novel α-synuclein-GFP mouse model displays progressive motor impairment, olfactory dysfunction and accumulation of α-synuclein-GFP.

    Christian Hansen, Tomas Björklund, Petit, G., Lundblad, M., Murmu, R., Brundin, P. & Jia-Yi Li, 2013, In : Neurobiology of Disease. 56C, April,30, p. 145-155

    Research output: Contribution to journalArticle

Previous 1 2 Next